Our group investigates the so-called 'third circulation', the lymphatics. We evaluate how inflammation contributes to lymphedema, a condition that affects hundreds of millions around the world. Working with our collaborator, Dr. Stanley Rockson, one of the leading clinical lymphedema experts in the world, we have helped develop the first medical therapies for this condition. Our lab also evaluates how lymphatic injury contributes to disease evolution in pulmonary hypertension and lung transplantation.